Dyne Therapeutics (DYN) Other Operating Expenses (2021 - 2026)
Dyne Therapeutics (DYN) recorded quarterly Other Operating Expenses of -$133000.0 in Q1 2026, up 53.98% quarter-over-quarter from -$289000.0 in Q4 2025, and down 49.44% on a YoY basis from -$263044.4 in Q1 2025.
Dyne Therapeutics (DYN) Other Operating Expenses (2021 - 2026) Analysis & Trends
Dyne Therapeutics' Other Operating Expenses history runs 6 years deep, the most recent figure standing at -$133000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 49.44% year-over-year to -$133000.0; the TTM figure through Mar 2026 stood at -$1.7 million (down 65.87% YoY), while the FY2025 annual figure was -$1.7 million, down 273.79% from the prior year.
- Other Operating Expenses was -$133000.0 for Q1 2026 at Dyne Therapeutics, up from -$289000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $506000.0 in Q1 2024 to a low of -$1.6 million in Q2 2025.
- Historically, Other Operating Expenses has averaged -$220705.9 across 5 years, with a median of -$126000.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses sank 3830.0% in 2023, then soared 334.26% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at -$24000.0 in 2022, then plunged by 2820.83% to -$701000.0 in 2023, then soared by 96.29% to -$26000.0 in 2024, then slumped by 1011.54% to -$289000.0 in 2025, then soared by 53.98% to -$133000.0 in 2026.
- The last three Other Operating Expenses figures came in at -$133000.0 (Q1 2026), -$289000.0 (Q4 2025), and $279000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133,000.00 |
| Dec 31, 2025 | -289,000.00 |
| Sep 30, 2025 | 279,000.00 |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | -89,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | -742,000.00 |
| Jun 30, 2024 | -192,000.00 |
| Mar 31, 2024 | 506,000.00 |
| Dec 31, 2023 | -701,000.00 |
| Sep 30, 2023 | -126,000.00 |
| Jun 30, 2023 | -373,000.00 |
| Mar 31, 2023 | -216,000.00 |
| Dec 31, 2022 | -24,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | -30,000.00 |
| Dec 31, 2021 | -8,000.00 |